Abstract
These studies characterized human α4β2 neuronal nicotinic receptors stably expressed in a human epithelial cell line (SH-EP1). Receptors in transfected SH-EP1-hα4β2 cells were functional, as determined by increases in intracellular Ca2+ in response to a nicotine stimulus. Nicotine increased Fura-2 fluorescence in a concentration-dependent manner with an apparent EC50 of 2.4 μM, a response that was blocked by the specific antagonist mecamylamine. When cells were incubated in 50 nM nicotine for 24 hours, the Ca2+ response inactivated by 44%, an effect that recovered within 24 hours. SH-EP1-hα4β2 cells expressed a single class of high affinity binding sites for [3H]cytisine with a Kd of 0.63 ± 0.08 nM and a Bmax of 6797 ± 732 femtomoles/mg protein. Incubation of cells with 50 nM nicotine for 24 hours increased the Bmax by 45% without changing affinity, a concentration-dependent effect with an EC50 of 58.6 nM. The nicotine-induced up regulation was reversible, and control values were achieved within 24 hours. Results indicate that SH-EP1-hα4β2 cells may be a good model system to study regulation of human α4β2 receptors, the most abundant nicotinic receptor subtype in brain.
Similar content being viewed by others
REFERENCES
Wada, E., Wada, K., Boulter, J., Deneris, E., Heinemann, S., Patrick, J., and Swanson, L. W. 1989. Distribution of alpha2, alpha3, alpha4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in rat. J. Comp. Neurol. 284:314–335.
Whiting, P. J., Schoepfer, R., Conroy, W. G., Gore, M. J., Keyser, K. T., Shimasaki, S., Esch, F., and Lindstrom, J. M. 1991. Expression of nicotinic acetylcholine receptor subtypes in brain and retina. Mol. Brain Res. 10:61–70.
Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., and Kellar, K. J. 1992. A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment. Mol. Pharmacol. 41:31–37.
Hsu, Y.-N., Amin, J., Weiss, D. S., and Wecker, L. 1996. Sustained nicotine exposure differentially affects α3β2 and α4β2 neuronal nicotinic receptors expressed in Xenopus oocytes. J. Neurochem. 66:667–675.
Fenster, C. P., Whitworth, T. L., Sheffield, E. B., Quick, M. W., and Lester, R. A. J. 1999. Upregulation of surface α4β2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine. J. Neurosci. 19:4804–4814.
Gopalakrishnan, M., Monteggia, L. M., Anderson, D. J., Molinari, E. J., Piattoni-Kaplan, M., Donnelly-Roberts, D., Arneric, S. P., and Sullivan, J. P. 1996. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine α4β2 receptor. J. Pharmacol. Exp. Ther. 276:289–297.
Eilers, H., Schaeffer, E., Bickler, P. E., and Forsayeth, J. R. 1997. Functional deactivation of the major neuronal nicotinic receptor caused by nicotine and a protein kinase C-dependent mechanism. Mol. Pharmacol. 52:1105–1112.
Peng, J.-H., Eaton, J. B., Eisenhour, C. M., Fryer, J. D., Lucero, L., and Lukas, R. J. 1999. Properties of stably and heterologously-expressed human α4β2-nicotinic acetylcholine receptors (nAChR). Neurosci. Abst. 25:1723.
Lukas, R. J., Norman, S. A., and Lucero, L. 1993. Characterization of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line. Mol. Cell. Neurosci. 4:1–12.
Biedler, J. L., Roffler-Tarlov, S., Schachner, M., and Freedman, L. S. 1978. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38:3751–3757.
Ross, R. A., Spengler, B. A., and Biedler, J. L. 1983. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl. Cancer Inst. 71:741–747.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265–275.
Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685.
Grynkiewicz, G., Poenie, M., and Tsien, R. Y. 1985. A new generation of Ca+2 indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440–3450.
Pacheco, M. A. and Jope, R. S. 1999. Modulation of carbacholstimulated AP-1 DNA binding activity by therapeutic agents for bipolar disorder in human neuroblastoma SH-SY5Y cells. Mol. Brain Res. 72:138–146.
Pabreza, L. A., Dhawan, S., and Kellar, K. J. 1991. [3H]Cytisine binding to nicotinic cholinergic receptors in brain. Mol. Pharmacol. 39:9–12.
Coutcher, J. B., Crawley, G., and Wecker, L. 1992. Dietary choline supplementation increases the density of nicotine binding sites in brain. J. Pharmacol. Exp. Ther. 262:1128–1132.
Whiting, P. and Lindstrom, J. 1987. Purification and characterization of a nicotinic acetylcholine receptor from rat brain. Proc. Natl. Acad. Sci. 84:595–599.
Nakayama, H., Shirase, M., Nakashima, T., Kurogochi, Y., and Lindstrom, J. M. 1990. Affinity purification of nicotinic acetylcholine receptor from rat brain. Mol. Brain Res. 7:221–226.
Wecker, L., Guo, X., Rycerz, A. M., and Edwards, S. C. 2001. Cyclic AMP-dependent protein kinase (PKA) and protein kinase C phosphorylate sites in the amino acid sequence corresponding to the M3/M4 cytoplasmic domain of α4 neuronal nicotinic receptor subunits. J. Neurochem. 76:711–720.
Xiao, Y., Meyer, E. L., Thompson, J. M., Surin, A., Wroblewski, J., and Kellar, K. J. 1998. Rat α3/β4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: Pharmacology of ligand binding and function. Mol. Pharmacol. 54:322–333.
Lipiello, P. M. and Fernandes, K. G. 1986. The binding of L-[3H]nicotine to a single class of high affinity sites in rat brain membranes. Mol. Pharmacol. 29:448–454.
Martino-Barrows, A. M. and Kellar, K. J. 1987. [3H]Acetylcholine and [3H](–) nicotine label the same recognition site in rat brain. Mol. Pharmacol. 31:169–174.
Benwell, M. E. M., Balfour, D. J. K., and Anderson, J. M. 1988. Evidence that tobacco smoking increases the density of (–)-[3H]nicotine binding sites in human brain. J. Neurochem. 50:1243–1247.
Kellar, K. J., Whitehouse, P. J., Martino-Barrows, A. M., Marcus, K., and Price, D. L. 1987. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex. Brain Res. 436:62–68.
Hall, M., Zerbe, L., Leonard, S., and Freedman, R. 1993. Characterization of [3H]cytisine binding to human brain membrane preparations. Brain Res. 600:127–133.
Davila-Garcia, M. I., Houghtling, R. A., Qasba, S. S., and Kellar, K. J. 1999. Nicotinic receptor binding sites in rat primary neuronal cells in culture: Characterization and their regulation by chronic nicotine. Mol. Brain Res. 66:14–23.
Schwartz, R. D. and Kellar, K. J. 1985. In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J. Neurochem. 45:427–433.
Hulihan-Giblin, B. A., Lumpkin, M. D., and Kellar, K. J. 1990. Effects of chronic administration of nicotine on prolactin release in the rat: Inactivation of prolactin response by repeated injections of nicotine. J. Pharmacol. Exp. Ther. 252:21–25.
Paradiso, K. and Brehm, P. 1998. Long-term desensitization of nicotinic acetylcholine receptors is regulated via protein kinase A-mediated phosphorylation. J. Neurosci. 18:9227–9237.
Fenster, C. P., Beckman, M. L., Parker, J. C., Sheffield, E. B., Whitworth, T. L., Quick, M. W., and Lester, R. A. J. 1999. Regulation of α4β2 nicotinic receptor desensitization by calcium and protein kinase C. Mol. Pharmacol. 55:432–443.
Viseshakul, N., Figl, A., Lytle, C., and Cohen B. N. 1998. The α4 subunit of rat α4β2 nicotinic receptors is phosphorylated in vivo. Mol. Brain Res. 59:100–104.
Gopalakrishnan, M., Molinari, E. J., and Sullivan, J. P. 1997. Regulation of human α4β2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways. Mol. Pharmacol. 52:524–534.
Hsu, Y.-N., Edwards, S. C., and Wecker, L. 1997. Nicotine enhances the cyclic AMP-dependent protein kinase-mediated phosphorylation of α4 subunits of neuronal nicotinic receptors. J. Neurochem. 69:2427–2431.
Monteggia, L. M., Gopalakrishnan, M., Touma, E., Idler, K. B., Nash, N., Americ, S. P., Sullivan, J. P., and Giordano, T. 1995. Cloning and transient expression of genes encoding the human α4 and β2 neuronal nicotinic acetylcholine receptor (nAChR) subunits. Gene 155:189–193.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pacheco, M.A., Pastoor, T.E., Lukas, R.J. et al. Characterization of Human α4β2 Neuronal Nicotinic Receptors Stably Expressed in SH-EP1 Cells. Neurochem Res 26, 683–693 (2001). https://doi.org/10.1023/A:1010995521851
Issue Date:
DOI: https://doi.org/10.1023/A:1010995521851